|
2021 Journal Article Correction: McCart Reed et al. The Genomic Landscape of Lobular Breast Cancer. Cancers 2021, 13, 1950McCart Reed, Amy E., Foong, Samuel, Kutasovic, Jamie R., Nones, Katia, Waddell, Nicola, Lakhani, Sunil R. and Simpson, Peter T. (2021). Correction: McCart Reed et al. The Genomic Landscape of Lobular Breast Cancer. Cancers 2021, 13, 1950. Cancers, 13 (16) 4010, 4010. doi: 10.3390/cancers13164010 |
|
2021 Journal Article SP142 PD-L1 scoring shows high interobserver and intraobserver agreement in triple-negative breast carcinoma but overall low percentage agreement with other PD-L1 clones SP263 and 22C3Pang, Jia-Min B., Castles, Belinda, Byrne, David J., Button, Peter, Hendry, Shona, Lakhani, Sunil R., Sivasubramaniam, Vanathi, Cooper, Wendy A., Armes, Jane, Millar, Ewan K.A., Raymond, Wendy, Roberts-Thomson, Samuel, Kumar, Beena, Burr, Marian, Selinger, Christina, Harvey, Kate, Chan, Charles, Beith, Jane, Clouston, David, O'Toole, Sandra A. and Fox, Stephen B. (2021). SP142 PD-L1 scoring shows high interobserver and intraobserver agreement in triple-negative breast carcinoma but overall low percentage agreement with other PD-L1 clones SP263 and 22C3. American Journal of Surgical Pathology, 45 (8), 1108-1117. doi: 10.1097/PAS.0000000000001701 |
|
2021 Journal Article Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancerTutt, Andrew N. J., Garber, Judy E., Kaufman, Bella, Viale, Giuseppe, Fumagalli, Debora, Rastogi, Priya, Gelber, Richard D., de Azambuja, Evandro, Fielding, Anitra, Balmaña, Judith, Domchek, Susan M., Gelmon, Karen A., Hollingsworth, Simon J., Korde, Larissa A., Linderholm, Barbro, Bandos, Hanna, Senkus, Elżbieta, Suga, Jennifer M., Shao, Zhimin, Pippas, Andrew W., Nowecki, Zbigniew, Huzarski, Tomasz, Ganz, Patricia A., Lucas, Peter C., Baker, Nigel, Loibl, Sibylle, McConnell, Robin, Piccart, Martine, Schmutzler, Rita ... Geyer, Charles E. (2021). Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer. New England Journal of Medicine, 384 (25), 2394-2405. doi: 10.1056/NEJMoa2105215 |
|
2021 Conference Publication OlympiA: A phase III, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)adjuvant chemotherapy in patients with germline BRCA1/2 mutations and high-risk HER2-negative early breast cancerTutt, Andrew, Garber, Judy Ellen, Kaufman, Bella, Viale, Giuseppe, Fumagalli, Debora, Rastogi, Priya, Gelber, Richard D., de Azambuja, Evandro, Fielding, Anitra, Gelpi, Judith Balmana, Gelmon, Karen A., Baker, Nigel, Arahmani, Amal, Senkus-Konefka, Elzbieta, Mc Fadden, Eleanor, Karantza, Vassiliki, Lakhani, Sunil R., Yothers, Greg, Campbell, Christine and Geyer, Charles E. (2021). OlympiA: A phase III, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)adjuvant chemotherapy in patients with germline BRCA1/2 mutations and high-risk HER2-negative early breast cancer. Virtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 04-08, 2021. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2021.39.15_suppl.LBA1 |
|
2021 Journal Article Altered calcium influx pathways in cancer-associated fibroblastsSadras, Francisco, Stewart, Teneale A., Robitaille, Mélanie, Peters, Amelia A., Croft, Priyakshi Kalita-de, Soon, Patsy S., Saunus, Jodi M., Lakhani, Sunil R., Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2021). Altered calcium influx pathways in cancer-associated fibroblasts. Biomedicines, 9 (6) 680, 1-13. doi: 10.3390/biomedicines9060680 |
|
2021 Journal Article Characterization of immune cell subsets of tumor infiltrating lymphocytes in brain metastasesCroft, Priyakshi Kalita-de, Chittoory, Haarika, Nguyen, Tam H., Saunus, Jodi M., Kim, Woo Gyeong, Reed, Amy E. McCart, Lim, Malcolm, De Luca, Xavier M., Ferguson, Kaltin, Niland, Colleen, Mazzieri, Roberta, Dolcetti, Riccardo, Simpson, Peter T. and Lakhani, Sunil R. (2021). Characterization of immune cell subsets of tumor infiltrating lymphocytes in brain metastases. Biology, 10 (5) 425, 425. doi: 10.3390/biology10050425 |
|
2021 Journal Article The genomic landscape of lobular breast cancerMcCart Reed, Amy E., Foong, Samuel, Kutasovic, Jamie R., Nones, Katia, Waddell, Nicola, Lakhani, Sunil R. and Simpson, Peter T. (2021). The genomic landscape of lobular breast cancer. Cancers, 13 (8) 1950, 1950. doi: 10.3390/cancers13081950 |
|
2021 Journal Article Tumor signature analysis implicates hereditary cancer genes in endometrial cancer developmentKondrashova, Olga, Shamsani, Jannah, O’Mara, Tracy A., Newell, Felicity, Reed, Amy E. McCart, Lakhani, Sunil R., Kirk, Judy, Pearson, John V., Waddell, Nicola and Spurdle, Amanda B. (2021). Tumor signature analysis implicates hereditary cancer genes in endometrial cancer development. Cancers, 13 (8) 1762, 1-16. doi: 10.3390/cancers13081762 |
|
2021 Journal Article Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for managementRakha, Emad A., Quinn, Cecily M., Foschini, Maria Pia, Munoz Martin, Monica, Dabbs, David J., Lakhani, Sunil, Varga, Zsuzsanna, Pinder, Sarah E., Schmitt, Fernando C., Reis-Filho, Jorge S., Fox, Stephen B., Ellis, Ian O., Tan, Puay-Hoon and Mihai, Raluca (2021). Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for management. Histopathology, 78 (5), 759-771. doi: 10.1111/his.14290 |
|
2021 Journal Article Spatial profiling technologies and applications for brain cancersKalita-de Croft, Priyakshi, Rad, Habib Sadeghi, Gasper, Harry, O'Byrne, Ken, Lakhani, Sunil R. and Kulasinghe, Arutha (2021). Spatial profiling technologies and applications for brain cancers. Expert Review of Molecular Diagnostics, 21 (3), 323-332. doi: 10.1080/14737159.2021.1900735 |
|
2021 Journal Article CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancersJohnson, Nichola, Maguire, Sarah, Morra, Anna, Kapoor, Pooja Middha, Tomczyk, Katarzyna, Jones, Michael E., Schoemaker, Minouk J., Gilham, Clare, Bolla, Manjeet K., Wang, Qin, Dennis, Joe, Ahearn, Thomas U., Andrulis, Irene L., Anton-Culver, Hoda, Antonenkova, Natalia N., Arndt, Volker, Aronson, Kristan J., Augustinsson, Annelie, Baynes, Caroline, Freeman, Laura E. Beane, Beckmann, Matthias W., Benitez, Javier, Bermisheva, Marina, Blomqvist, Carl, Boeckx, Bram, Bogdanova, Natalia V., Bojesen, Stig E., Brauch, Hiltrud, Brenner, Hermann ... Fletcher, Olivia (2021). CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers. British Journal of Cancer, 124 (4), 842-854. doi: 10.1038/s41416-020-01185-w |
|
2021 Journal Article An update on the molecular pathology of metaplastic breast cancerMcCart Reed, Amy E., Kalaw, Emarene M. and Lakhani, Sunil R. (2021). An update on the molecular pathology of metaplastic breast cancer. Breast Cancer, 13, 161-170. doi: 10.2147/bctt.s296784 |
|
2021 Journal Article Invasive lobular carcinoma of the breast: the increasing importance of this special subtypeMcCart Reed, Amy E., Kalinowski, Lauren, Simpson, Peter T. and Lakhani, Sunil R. (2021). Invasive lobular carcinoma of the breast: the increasing importance of this special subtype. Breast Cancer Research, 23 (1) 6, 6. doi: 10.1186/s13058-020-01384-6 |
|
2020 Journal Article Divergent mutational processes distinguish hypoxic and normoxic tumoursBhandari, Vinayak, Li, Constance H., Bristow, Robert G., Boutros, Paul C., Aaltonen, Lauri A., Abascal, Federico, Abeshouse, Adam, Aburatani, Hiroyuki, Adams, David J., Agrawal, Nishant, Ahn, Keun Soo, Ahn, Sung-Min, Aikata, Hiroshi, Akbani, Rehan, Akdemir, Kadir C., Al-Ahmadie, Hikmat, Al-Sedairy, Sultan T., Al-Shahrour, Fatima, Alawi, Malik, Albert, Monique, Aldape, Kenneth, Alexandrov, Ludmil B., Ally, Adrian, Alsop, Kathryn, Alvarez, Eva G., Amary, Fernanda, Amin, Samirkumar B., Aminou, Brice, Ammerpohl, Ole ... PCAWG Consortium (2020). Divergent mutational processes distinguish hypoxic and normoxic tumours. Nature Communications, 11 (1) 737. doi: 10.1038/s41467-019-14052-x |
|
2020 Journal Article Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trialsHudeček, Jan, Voorwerk, Leonie, van Seijen, Maartje, Nederlof, Iris, de Maaker, Michiel, van den Berg, Jose, van de Vijver, Koen K., Sikorska, Karolina, Adams, Sylvia, Demaria, Sandra, Viale, Giuseppe, Nielsen, Torsten O., Badve, Sunil S., Michiels, Stefan, Symmans, William Fraser, Sotiriou, Christos, Rimm, David L., Hewitt, Stephen M., Denkert, Carsten, Loibl, Sibylle, Loi, Sherene, Bartlett, John M. S., Pruneri, Giancarlo, Dillon, Deborah A., Cheang, Maggie C. U., Tutt, Andrew, Hall, Jacqueline A., Kos, Zuzana, Salgado, Roberto ... and International Immuno-Oncology Biomarker Working Group (2020). Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials. npj Breast Cancer, 6 (1) 15. doi: 10.1038/s41523-020-0155-1 |
|
2020 Journal Article Sex differences in oncogenic mutational processesLi, Constance H., Prokopec, Stephenie D., Sun, Ren X., Yousif, Fouad, Schmitz, Nathaniel, Al-Shahrour, Fatima, Atwal, Gurnit, Bailey, Peter J., Biankin, Andrew V., Boutros, Paul C., Campbell, Peter J., Chang, David K., Cooke, Susanna L., Deshpande, Vikram, Faltas, Bishoy M., Faquin, William C., Garraway, Levi, Getz, Gad, Grimmond, Sean M., Haider, Syed, Hoadley, Katherine A., Jiao, Wei, Kaiser, Vera B., Karlić, Rosa, Kato, Mamoru, Kübler, Kirsten, Lazar, Alexander J., Li, Constance H., Louis, David N. ... Lakhani, Sunil R. (2020). Sex differences in oncogenic mutational processes. Nature Communications, 11 (1) 4330. doi: 10.1038/s41467-020-17359-2 |
|
2020 Journal Article Inferring structural variant cancer cell fractionCmero, Marek, Yuan, Ke, Ong, Cheng Soon, Schröder, Jan, Adams, David J., Anur, Pavana, Beroukhim, Rameen, Boutros, Paul C., Bowtell, David D. L., Campbell, Peter J., Cao, Shaolong, Christie, Elizabeth L., Cun, Yupeng, Dawson, Kevin J., Demeulemeester, Jonas, Dentro, Stefan C., Deshwar, Amit G., Donmez, Nilgun, Drews, Ruben M., Eils, Roland, Fan, Yu, Fittall, Matthew W., Garsed, Dale W., Gerstung, Moritz, Getz, Gad, Gonzalez, Santiago, Ha, Gavin, Haase, Kerstin, Imielinski, Marcin ... von Mering, Christian (2020). Inferring structural variant cancer cell fraction. Nature Communications, 11 (1) 730. doi: 10.1038/s41467-020-14351-8 |
|
2020 Journal Article Lobular carcinoma in situ: diagnostic criteria and molecular correlatesSokolova, Anna and Lakhani, Sunil R. (2020). Lobular carcinoma in situ: diagnostic criteria and molecular correlates. Modern Pathology, 34 (S1), 8-14. doi: 10.1038/s41379-020-00689-3 |
|
2020 Journal Article Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1Kalaw, Emarene, Lim, Malcolm, Kutasovic, Jamie R., Sokolova, Anna, Taege, Lucinda, Johnstone, Kate, Bennett, James, Saunus, Jodi M., Niland, Colleen, Ferguson, Kaltin, Gresshoff, Irma, Bettington, Mark, Pathmanathan, Nirmala, Tse, Gary M., Papadimos, David, Pathmanathan, Rajadurai, Harris, Gavin, Yamaguchi, Rin, Tan, Puay Hoon, Fox, Stephen, O’Toole, Sandra A., Simpson, Peter T., Lakhani, Sunil R. and McCart Reed, Amy E. (2020). Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1. British Journal of Cancer, 123 (11), 1665-1672. doi: 10.1038/s41416-020-01065-3 |
|
2020 Journal Article Phenotypic drift in metastatic progression of breast cancer: a case report with histologically heterogeneous lesions that are clonally relatedKutasovic, Jamie R., McCart Reed, Amy E., Sokolova, Anna, Jayanthan, Janani, Da Silva, Leonard, Simpson, Peter T. and Lakhani, Sunil R. (2020). Phenotypic drift in metastatic progression of breast cancer: a case report with histologically heterogeneous lesions that are clonally related. Clinical Case Reports, 8 (12) ccr3.3257, 2725-2731. doi: 10.1002/ccr3.3257 |
